Universal Health International (HKG:2211) indirect subsidiary Heilongjiang Jintian Aixin Pharmaceutical Distribution sold a 43.78% stake in Jilin Jintian Universal Health Group Capsules to a capsule manufacturing investor, according to a Tuesday filing with the Hong Kong Exchange.
The sale price for the stake in the hollow capsule manufacturer is 43 million yuan.
Completion is slated within three business dates once the conditions precedent are satisfied, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.